SCHEMBL24740347

SCHEMBL24740347

CC(C)NC(=O)c1cc2ccc(F)c(Cl)c2[nH]1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 4/20 0.61
ALPL P05186 2/20 0.43
EIF4A3 P38919 1/20 0.43
AR P10275 1/20 0.40
ALB P02768 1/20 0.38
IL2 P60568 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
RECQL P46063 1/20 0.38
PYGL P06737 1/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA1 P30542 1/20 0.37
PTK2 Q05397 1/20 0.37
PTK2B Q14289 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25768432 0.87 ALOX15 (0.47) ALOX15EIF4A3ARALBIL2
SCHEMBL24019762 0.86 ALOX15 (0.60) ALOX15ALPLEIF4A3PYGLMAPT
SCHEMBL25758822 0.86 ALOX15 (0.57) ALOX15ALPLEIF4A3ARALB
SCHEMBL25758845 0.84 ALOX15 (0.54) ALOX15ALPLEIF4A3ARALB
SCHEMBL24019964 0.84 ALOX15 (0.58) ALOX15ALPLEIF4A3ARMAPT
SCHEMBL8959558 0.82 XDH (0.47) ALOX15ALPLEIF4A3MAPT
SCHEMBL24019700 0.81 ALB (0.55) ALOX15ARALBIL2HRH4
SCHEMBL25812180 0.80 EIF4A3 (0.42) ALOX15EIF4A3HRH4MEN1KMT2A
SCHEMBL24019957 0.80 ALOX15 (0.52) ALOX15ALPLEIF4A3ALBIL2
SCHEMBL25758821 0.79 IDO1 (0.50) ALOX15ALPLEIF4A3ALBIL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof Pardes Biosciences, Inc. (US) 2022-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11524940-B1 Inhibitors of cysteine proteases and methods of use thereof CTRL, CTSV, CTSL ALOX15 1749/4885ALPL 1768/4885EIF4A3 608/4885
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF CTRL, CTSL, CTSV ALOX15 1455/4885ALPL 1886/4885EIF4A3 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.